These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23166685)

  • 21. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms.
    Daffis S; Samuel MA; Keller BC; Gale M; Diamond MS
    PLoS Pathog; 2007 Jul; 3(7):e106. PubMed ID: 17676997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-intrinsic innate immune control of West Nile virus infection.
    Diamond MS; Gale M
    Trends Immunol; 2012 Oct; 33(10):522-30. PubMed ID: 22726607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
    J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.
    Samuel MA; Diamond MS
    J Virol; 2005 Nov; 79(21):13350-61. PubMed ID: 16227257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.
    Gershoni-Yahalom O; Landes S; Kleiman-Shoval S; Ben-Nathan D; Kam M; Lachmi BE; Khinich Y; Simanov M; Samina I; Eitan A; Cohen IR; Rager-Zisman B; Porgador A
    Immunology; 2010 Aug; 130(4):527-35. PubMed ID: 20331473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice.
    Xie G; Luo H; Pang L; Peng BH; Winkelmann E; McGruder B; Hesse J; Whiteman M; Campbell G; Milligan GN; Cong Y; Barrett AD; Wang T
    J Virol; 2016 Feb; 90(3):1333-44. PubMed ID: 26581984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice.
    Rodríguez-Pulido M; Borrego B; Sobrino F; Sáiz M
    J Virol; 2011 Jul; 85(13):6492-501. PubMed ID: 21525336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.
    Bonafé N; Rininger JA; Chubet RG; Foellmer HG; Fader S; Anderson JF; Bushmich SL; Anthony K; Ledizet M; Fikrig E; Koski RA; Kaplan P
    Vaccine; 2009 Jan; 27(2):213-22. PubMed ID: 18996430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT5: a Target of Antagonism by Neurotropic Flaviviruses.
    Zimmerman MG; Bowen JR; McDonald CE; Young E; Baric RS; Pulendran B; Suthar MS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system.
    Szretter KJ; Daffis S; Patel J; Suthar MS; Klein RS; Gale M; Diamond MS
    J Virol; 2010 Dec; 84(23):12125-38. PubMed ID: 20881045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The host immunologic response to West Nile encephalitis virus.
    Diamond MS; Mehlhop E; Oliphant T; Samuel MA
    Front Biosci (Landmark Ed); 2009 Jan; 14(8):3024-34. PubMed ID: 19273254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. West Nile virus: recent trends in diagnosis and vaccine development.
    Dauphin G; Zientara S
    Vaccine; 2007 Jul; 25(30):5563-76. PubMed ID: 17292514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious clones of novel lineage 1 and lineage 2 West Nile virus strains WNV-TX02 and WNV-Madagascar.
    Suthar MS; Brassil MM; Blahnik G; Gale M
    J Virol; 2012 Jul; 86(14):7704-9. PubMed ID: 22573862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vector derived artificial miRNA mediated inhibition of West Nile virus replication and protein expression.
    Karothia D; Kumar Dash P; Parida M; Bhagyawant SS; Kumar JS
    Gene; 2020 Mar; 729():144300. PubMed ID: 31884102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.
    Brien JD; Uhrlaub JL; Nikolich-Zugich J
    J Immunol; 2008 Dec; 181(12):8568-75. PubMed ID: 19050276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Immune Responses of the Animal Hosts of West Nile Virus: A Comparison of Insects, Birds, and Mammals.
    Ahlers LRH; Goodman AG
    Front Cell Infect Microbiol; 2018; 8():96. PubMed ID: 29666784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
    Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus.
    Hofmeister Y; Planitzer CB; Farcet MR; Teschner W; Butterweck HA; Weber A; Holzer GW; Kreil TR
    J Virol; 2011 Feb; 85(4):1896-9. PubMed ID: 21123389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.